STRATA Skin Sciences, Inc. Announces Successful Completion of Debt RefinancingHomeMailNewsFinanceSportsEntertainmentSearchMobileMoreYahooSearchNo matching results for ''Tip: Try a valid symbol or a specific company name for relevant resultsSign inMailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)STRATA Skin Sciences, Inc. Announces Successful Completion of Debt RefinancingGlobeNewswireJanuary 6, 2020ReblogShareTweetShareSuccessfully extinguishes existing debt with a new commercial bank loan facility New fixed annual interest rate of 2.79%, reduces interest rate costs by approximately $700,000 HORSHAM, Pa., Jan. 06, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that it has closed a refinancing of its existing debt with a lower interest one-year cash-secured loan facility with Israel Discount Bank of New York, a multi-national commercial bank.The new loan, at a fixed interest rate of 2.79%, significantly lowers the Company’s interest expense for 2020.  The proceeds of the new loan facility were used to repay the Company’s outstanding term note with MidCap Financial.Dr. Dolev Rafaeli, the Company’s President and CEO stated, “This refinancing and new commercial bank loan facility is a testament to our financial strength and ability to generate cash flow. With it, we are able to significantly lower our cost of capital and increase our operational flexibility. Additionally, this refinancing allows the Company to be opportunistic in its strategic plans. We look forward to continuing to execute on our strategy of expanding our install base and investing in direct-to-consumer marketing of XTRAC.”About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)   STRATA Skin Sciences is a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTRAC® excimer laser and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; and the STRATAPEN® MicroSystem, marketed specifically for the intended use of micropigmentation.The Company’s proprietary XTRAC® excimer laser delivers a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 35 million patients in the United States alone. The technology is covered by multiple patents, including exclusive rights for patents for the delivery of treatment to vitiligo patients.STRATA’s unique business model leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.The XTRAC business has used this proven DTC model to grow its domestic dermatology partner network to over 784 clinics, with a worldwide installed base of over 2,000 devices. The Company is able to offer 90% of DTC patients an introduction to physicians prescribing a reimbursable solution, using XTRAC, within a 10-mile radius of their house. The Company is a leader in dermatology in-clinic business generation for its partners.Safe HarborThis press release, and oral statements made regarding the subjects of this release contains "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995, or the Reform Act, which may include, but are not limited to, statements regarding the Company’s revenue growth estimates, plans, objectives, expectations and intentions and other statements contained in this press release that are not historical facts, including statements identified by words such as “believe,” “plan,” “seek,” “expect,” “intend,” “estimate,” “anticipate,” “will,” and similar expressions. All statements addressing the Company’s ability to generate the anticipated revenue stream, the Company’s ability to generate sufficient cash flow to fund the Company’s ongoing operations and research and development activities beginning at any time in the future, litigation and regulatory proceedings to which the Company might be subject; the Company’s ability to implement business strategies, including its acquisition, business development and comeback strategies; the Company’s acquisition and business development strategy may not be successful in locating advantageous targets; the Company’s ability to successfully integrate any assets, liabilities, customers, systems and management personnel it acquires into its operations and its ability to realize related revenue synergies, strategic gains and cost savings may be significantly harder to achieve, if at all, or may take longer to achieve; potential goodwill impairment charges, future impairment charges and fluctuations in the fair values of reporting units or of assets in the event projected financial results are not achieved within expected time frames; the Company’s debt and debt service requirements which may restrict its operational and financial flexibility, as well as imposing unfavorable interest and financing costs; the Company’s ability to maintain its existing credit facilities or obtain satisfactory new credit facilities; regulatory and political factors or conditions affecting the Company and/or the medical device industry in general; the public’s reaction to the Company’s new advertisements and marketing campaigns under development, and the Company’s ability to build a leading franchise in dermatology and aesthetics, and the Company’s ability to grow revenues and sustain that growth as well as statements expressing optimism or pessimism about future operating results are forward-looking statements within the meaning of the Reform Act. The forward-looking statements are based on management’s current views and assumptions regarding future events and operating performance, and are inherently subject to significant business, economic, and competitive uncertainties and contingencies and changes in circumstances, many of which are beyond the Company’s control. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not undertake any obligation to update or revise these statements to reflect events or circumstances occurring after the date of this press release.Story continuesAlthough the Company does not make forward-looking statements unless it believes it has a reasonable basis for doing so, the Company cannot guarantee their accuracy. The foregoing factors, among others, could cause actual results to differ materially from those described in these forward-looking statements. For a list of other factors which could affect the Company’s results, including revenue growth estimates, see the Company’s filings with the Securities and Exchange Commission, including “Cautionary Note Regarding Forward-Looking Statements,” “Item 1A. Risk Factors,” and “Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations” set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018. No undue reliance should be placed on any forward-looking statements.Investor Contacts: Matthew Hill, Chief Financial Officer   Matthew Picciano, Managing Director
STRATA Skin Sciences, Inc.   LifeSci Advisors, LLC
215-619-3200   646-889-1200
ir@strataskin.com   mpicciano@lifesciadvisors.com  ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextConfidence returning for UK consumers and companies - surveysReutersConsumer-facing companies will be the first hit if the coronavirus spreads across the U.S.MarketWatchPittsburgh companies implement travel restrictions in response to coronavirus threatsAmerican City Business JournalsBeijing’s city government issued 10 anti-coronavirus rules for workplacesQuartzTop Marijuana Stocks on the NASDAQ for March 2020InvestopediaBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceBusinessTheStreet.comHere's When You Should Buy Stocks AgainThe S&P 500 kicked off the week Monday by gapping down 2.4%, the worst opening gap lower for the broad index since 1982. And it's followed up with consistent selling, putting the broad market on track for its worst week since the financial crisis of 2008. Is this finally the end of the rally that's propelled stocks more than 80% higher on a total-return basis over the past four years?BusinessYahoo FinanceStock market live updates: Stock futures climb after historic rout; coronavirus fears persistOn Thursday evening shortly after 6 p.m. ET, Dow futures (YM=F) were down 0.3%, S&P futures (ES=F) were down 0.4%, and Nasdaq futures (NQ=F) were down 0.3%. “Global markets were down $1.83 trillion today, with the U.S. down $1.33 trillion,“ S&P Dow Jones' Howard Silverblatt said in an email.BusinessUSA TODAYCoronavirus fears spook stocks: Here's how to keep a cool head and protect your 401(k)Sign up here Here are four moves experts say could help protect your investments during volatile periods, such as the bumpy stretch caused by the coronavirus: 401(k): Coronavirus fears shouldn't stop you from investing in stocks Monitoring markets: Dow jumps 300 points as investors assess economic fallout from virus 1. Review your investments Pay attention to where you're invested and which companies are most likely to be affected, portfolio managers say. Daniel Milan, managing partner at Southfield, Michigan-based Cornerstone Financial Services, says the effects from the virus outbreak on the stock market will be short-lived and has cautioned his clients to not let fear drive their investme...BusinessYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyGlobal financial markets plunged for the sixth consecutive day on Thursday, with coronavirus fears shaving over 1,100 points off the Dow (^DJI) — its biggest in history — and sending the S&P 500 (^GSPC) swooning to its fastest-ever correction. Global markets were down $1.83 trillion today, with the U.S. down $1.33 trillion,“ S&P Dow Jones' Howard Silverblatt said in an email. He added that over the past six days, global markets erased $6 trillion in wealth with U.S. markets losing $4 trillion.BusinessYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffSo every time stocks went up, bonds tailed off and vice-versa,” Academy Securities' Peter Tchir said on Yahoo Finance's The Final Round. All of a sudden, that behavior changed a little bit into the close yesterday. And making it even more dangerous to me, you saw oil fall off into the close.BusinessBloombergHow to Tell When Markets Finally Reach a BottomOr, when current Federal Reserve Chair Jerome Powell made his “dovish pivot” in January 2019 by saying the central bank would be “patient and flexible” when it came to considering future interest-rate increases. But what makes the current plunge different is that it's being driven by an event — the threat that the coronavirus will become worldwide pandemic — that is out of the control of monetary policy makers and Wall Street. So, there is unlikely to be some “magic” headline that scrolls across the computer screens of investors and traders that says it is over.BusinessYahoo Finance VideoWhat to watch in the markets: Friday, February 28After yet another volatile day of trading on Wall Street, Yahoo! Finance's Myles Udland discusses what to watch in the markets tomorrow,BusinessMarketWatchWait for these signals to buy coronavirus-battered stocks, says BNY Mellon strategistSome believe the next big fall in equities will come when we see a cluster of U.S. cases, which may partly explain why that popular past time of buying stocks on any dip seems less popular lately. Citigroup strategists are advising against buying equities right now, on the view that if a Federal Reserve lifeline is coming, it may not happen right away. Gov. Warsh argues for immediate, globally coordinated rate cut Our call of the day comes from BNY Mellon's chief strategist Alicia Levine, who has advice for those wanting to know when to buy beaten-down (and down) stocks.BusinessYahoo Finance CanadaTrading halted on TSX, citing order entry issueTrading on the TSX and TMX's other exchanges has been halted for the rest of the day as TMX investigates an order entry problem on its exchanges. A technical halt has been declared on TSX, TSXV & TSX Alpha,” said TMX in a statement posted to Twitter. In order to allow Participants to manage their orders, the market will remain in a Pre-Open state until further notice.BusinessInvestor's Business DailyDow Jones Futures Fall Sharply As Coronavirus Stock Market Correction Intensifies; Tesla, Nvidia, Beyond Meat Down LateDow Jones futures fell sharply in volatile action Thursday, along with S&P 500 futures and Nasdaq futures. The coronavirus stock market correction intensified Thursday, with the Dow Jones and other major indexes all falling more than 4%. The U.S. is monitoring thousands of people in California for possible Covid-19 infections, while coronavirus cases continued to spread.BusinessMarketWatchStock-market plunge ‘starting to feel a bit ridiculous,’ but don’t argue, says chart-watcherIt doesn't pay to fight the tape, but the stock market could be poised for a big-time rally once the current selloff subsides, a veteran chart-watcher said Thursday. “This move lower is starting to feel a bit ridiculous, but we try not to argue with Ms. Market,” said Mark Arbeter, president of Arbeter Investments, in a note. “If and when this thing turns, we should see some rip-roaring rally.”BusinessMarketWatchThese stocks have been crushed since the coronavirus began to take down the U.S. marketa href="https://www.marketwatch.com/story/these-stocks-have-been-crushed-since-the-coronavirus-began-to-take-down-the-us-market-2020-02-27? siteid=yhoof2" (DVN) Oil & Gas Production -31.0% -39.7% -55.7% 15.2% Royal Caribbean Cruises Ltd.BusinessTheStreet.comJim Cramer on Coronavirus: What It Means for Markets, Federal Reserve and MicrosoftJim Cramer has some thoughts on the markets, the Federal Reserve and Microsoft as coronavirus fears shake Wall Street. Stock futures declined sharply Thursday, putting Wall Street on pace for its worst week since the global financial crisis in 2008, as coronavirus infections accelerated and health officials confirmed that a California man contracted the disease despite having no travel links or contacts with those afflicted by the virus. The company warned investors that it will fall short of previously issued fiscal third-quarter sales guidance of between $10.75 billion and $11.15 billion for its "more personal computing" segment, which includes Windows OEM and Surface.BusinessYahoo FinanceBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'The company notched blistering sales growth in its retail (198%) and food service/restaurant segments (223%). Unclear if analysts will ding Beyond Meat for slowing sales growth at each segment compared to the third quarter. Beyond Meat founder and CEO Ethan Brown tells Yahoo Finance the quarter was “outstanding.”BusinessInvestor's Business DailyProtective Mask Maker Soars 340% This Week As Coronavirus SpiralsAlpha Pro Tech announced a spike in face mask orders amid the spiraling coronavirus outbreak, a day after disclosing earnings for the fourth quarter. APT stock soared, also boosting Lakeland Industries and Dow Jones Industrial Average component 3M. APT said Thursday it has booked about $14.1 million face mask orders since Jan. 27. That is up from the $10.4 million APT had reported just two weeks ago on Feb. 13.BusinessYahoo Finance VideoTrending Ticker: VIR Surges as Coronavirus fears persistAs the markets continue to fall, the biotech field is seeing a boost as companies race to develop vaccines and a cure. Vir Biotechnology Inc. shares surged over 60%, while Gilead Sciences stocks saw a bump of 4%.BusinessMarketWatchTrump talks about the stock market, and gets 1 out of 3 points rightStock markets do this all the time. Since Trump was elected president in November 2016, the Dow has risen from around 18,000 to around 27,000. Trump went on an extended riff blaming the market's fall on Tuesday's Democratic presidential debate.BusinessGuruFocus.comBattered Energy Stocks Are Now AlluringAPA 30-Year Financial Data The intrinsic value of APA Peter Lynch Chart of APA With all the bad news that has plagued the industry for the past several years, what makes the sector so attractive currently? Who in their right mind would want put their money in these companies, whose shares have been heading on a persistent downwards trajectory for over the past five years? Precisely becasue of the difficult times suffered by the energy stocks over the past few years, there is now a noticeable disconnect between energy and the overall market, which ascended to new highs recently while the battering of the trailing energy sector continued.BusinessInvestor's Business Daily'What's Going On, Moderna?' Investors Ask As Shares Go On A Wild RideModerna took biotech investors on a ride Thursday as MRNA stock rocketed, was halted and then plunged in a matter of hours. On the stock market today, MRNA stock toppled 10.3%, to 26.16. But in the early morning, shares of the biotech company skyrocketed more than 23% to a fresh high at 36.BusinessBarrons.comFear Has Overtaken This Market. How to Use It to Turn a Profit.In anticipation, the stock market has experienced some of its most dramatic losses in two years. The profound rotation away from risk assets into Treasury bonds earlier this week should be considered as a warning shot across the equity market's bow. Early next week, the Institute for Supply Management will release its February report on U.S. economic activity, and similar reports will be released that measure economic activity all over the world.Stock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffYahoo FinanceBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo FinanceWhat to watch in the markets: Friday, February 28Yahoo Finance VideoAdena Friedman joins Influencers with Andy SerwerYahoo Finance VideoWashington Redskins fire President Bruce AllenYahoo Finance VideoApple TV+ is now live — Here's how it compares to Disney+, HBO Max, Netflix, and othersYahoo FinanceCoronavirus won't stop Beyond Meat from entering China in 2020: CEO Ethan BrownYahoo FinanceBreaking down how China’s GDP goals will be impacted by the coronavirusYahoo Finance VideoCoronavirus will wipe out corporate profit growth in 2020 and may trigger recession: Goldman SachsYahoo FinanceStock market news: November 25, 2019Yahoo FinanceGap has a big new problem on its handsYahoo FinanceWall Street cites Bernie Sanders as a rival to the coronavirus as a market riskYahoo FinanceBeyond Meat shares surge, then tumble, after reporting earningsYahoo Finance VideoDid Trump give into pressure from the vaping industry?Yahoo Finance VideoMeth is making its comebackYahoo Finance Video